RespireRx Pharmaceuticals Inc (fka RSPI)

[moosedogger]

R&R's price target of $4.50 is a joke -- they're the same guys who had a $12 price target not too long ago.

R&R are good guys as far as I know.

$12 wasn't out of line- it could have gotten there if the hold hadn't happened a year ago.

Neuro had the same $12 target- and he's certainly as credible as they come, actually even more so.

$4.50 may seem high but are they talking post-FDA approval or before? I don't know.

BTW- weren't you extolling the possibility of $50 not that long ago? I think I recall you even mentioned that number to Stoll and he said something like (I'm paraphrasing) "I hope you're right but don't get your hopes up"

I think today is all about China

3-4 PM could be interesting.

cheers